• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伴有谱系转换的 KMT2A 重排白血病婴儿病例中 PAX5 改变。

PAX5 alterations in an infant case of KMT2A-rearranged leukemia with lineage switch.

机构信息

Department of Pediatrics, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

Department of Pediatrics, Kochi Health Sciences Center, Kochi, Japan.

出版信息

Cancer Sci. 2022 Jul;113(7):2472-2476. doi: 10.1111/cas.15380. Epub 2022 May 31.

DOI:10.1111/cas.15380
PMID:35467057
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9277256/
Abstract

Lineage switch is a rare event at leukemic relapse. While mostly known to occur in KMT2A-rearranged infant leukemia, the underlying mechanism is yet to be depicted. This case report describes a female infant who achieved remission of KMT2A-MLLT3-rearranged acute monocytic leukemia, but 6 months thereafter, relapsed as KMT2A-MLLT3-rearranged acute lymphocytic leukemia. Whole exome sequencing of the bone marrow obtained pre-post lineage switch revealed two somatic mutations of PAX5 in the relapse sample. These two PAX5 alterations were suggested to be loss of function, thus to have played the driver role in the lineage switch from acute monocytic leukemia to acute lymphocytic leukemia.

摘要

谱系转换是白血病复发的罕见事件。虽然这种现象主要发生在 KMT2A 重排的婴儿白血病中,但潜在的机制尚未被描述。本病例报告描述了一名女性婴儿,她患有 KMT2A-MLLT3 重排的急性单核细胞白血病,经治疗后获得缓解,但 6 个月后复发为 KMT2A-MLLT3 重排的急性淋巴细胞白血病。在谱系转换前后采集的骨髓进行全外显子测序,发现复发样本中有两个 PAX5 体细胞突变。这两个 PAX5 改变被认为是功能丧失,因此在急性单核细胞白血病向急性淋巴细胞白血病的谱系转换中起驱动作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/651d/9277256/c5a2259a2d29/CAS-113-2472-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/651d/9277256/06833c08a03f/CAS-113-2472-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/651d/9277256/c5a2259a2d29/CAS-113-2472-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/651d/9277256/06833c08a03f/CAS-113-2472-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/651d/9277256/c5a2259a2d29/CAS-113-2472-g003.jpg

相似文献

1
PAX5 alterations in an infant case of KMT2A-rearranged leukemia with lineage switch.伴有谱系转换的 KMT2A 重排白血病婴儿病例中 PAX5 改变。
Cancer Sci. 2022 Jul;113(7):2472-2476. doi: 10.1111/cas.15380. Epub 2022 May 31.
2
Therapy-induced Deletion in 11q23 Leading to Fusion of With and Development of B Lineage Acute Lymphoplastic Leukemia in a Child Treated for Acute Myeloid Leukemia Caused by t(9;11)(p21;q23)/.治疗诱导的 11q23 缺失导致融合和 B 系急性淋巴细胞白血病的发生,该患儿因 t(9;11)(p21;q23)/ 所致急性髓系白血病接受治疗。
Cancer Genomics Proteomics. 2021 Jan-Feb;18(1):67-81. doi: 10.21873/cgp.20242. Epub 2021 Jan 8.
3
Lineage Switch in an Infant B-Lymphoblastic Leukemia With t(1;11)(p32;q23); , Following Blinatumomab Therapy.婴儿 B 淋巴细胞白血病伴 t(1;11)(p32;q23); 经blinatumomab 治疗后出现谱系转换。
Pediatr Dev Pathol. 2021 Jul-Aug;24(4):378-382. doi: 10.1177/10935266211001308. Epub 2021 Mar 22.
4
-rearranged diffuse large B-cell lymphoma in a child: a case report and molecular characterization.儿童弥漫性大 B 细胞淋巴瘤的再分类:一例病例报告及分子特征。
Pediatr Hematol Oncol. 2021 Apr;38(3):281-289. doi: 10.1080/08880018.2020.1838013. Epub 2020 Nov 5.
5
Azacitidine successfully maintained the second remission in an infant with KMT2A-rearranged acute lymphoblastic leukemia who relapsed after unrelated cord blood transplantation.阿扎胞苷成功维持了一名KMT2A重排急性淋巴细胞白血病婴儿的第二次缓解,该婴儿在非亲缘脐血移植后复发。
Pediatr Blood Cancer. 2017 Dec;64(12). doi: 10.1002/pbc.26697. Epub 2017 Jul 4.
6
Distinct Responses to Menin Inhibition and Synergy with DOT1L Inhibition in -Rearranged Acute Lymphoblastic and Myeloid Leukemia.Menin 抑制和 DOT1L 抑制协同作用在 - 重排急性淋巴细胞白血病和髓系白血病中的不同反应。
Int J Mol Sci. 2024 May 30;25(11):6020. doi: 10.3390/ijms25116020.
7
KMT2A-rearranged infantile acute myeloid leukemia masquerading as juvenile myelomonocytic leukemia.伪装成青少年粒单核细胞白血病的KMT2A重排婴儿急性髓系白血病
Int J Hematol. 2018 Dec;108(6):665-669. doi: 10.1007/s12185-018-2522-3. Epub 2018 Aug 24.
8
Recent Developments and Evolving Therapeutic Strategies in KMT2A-Rearranged Acute Leukemia.KMT2A 重排急性白血病的最新进展和不断发展的治疗策略。
Cancer Med. 2024 Oct;13(20):e70326. doi: 10.1002/cam4.70326.
9
Extramedullary relapse of ()-rearranged acute lymphoblastic leukemia with lineage switch following blinatumomab.在使用博纳吐单抗后,伴有谱系转换的()重排急性淋巴细胞白血病的髓外复发
Blood. 2018 May 31;131(22):2507. doi: 10.1182/blood-2018-02-834911.
10
Myeloid lineage switch in rearranged acute lymphoblastic leukemia treated with lymphoid lineagedirected therapies.采用淋巴系定向疗法治疗的重排型急性淋巴细胞白血病中的髓系谱系转换
Haematologica. 2024 Jan 1;109(1):293-297. doi: 10.3324/haematol.2023.283705.

引用本文的文献

1
A shadow in the treatment of acute leukemia: lineage switch.急性白血病治疗中的一个难题:谱系转换。
Blood Sci. 2025 Mar 20;7(2):e00220. doi: 10.1097/BS9.0000000000000220. eCollection 2025 Jun.
2
Transcription factor networks link B-lymphocyte development and malignant transformation in leukemia.转录因子网络将白血病中的 B 淋巴细胞发育和恶性转化联系起来。
Genes Dev. 2023 Aug 1;37(15-16):703-723. doi: 10.1101/gad.349879.122. Epub 2023 Sep 6.
3
Clonal origin of KMT2A wild-type lineage-switch leukemia following CAR-T cell and blinatumomab therapy.

本文引用的文献

1
Delayed therapy initiation for a case with congenital leukemia with transient spontaneous regression.先天性白血病伴短暂自发消退病例的延迟治疗起始
Pediatr Hematol Oncol. 2022 Apr;39(3):286-290. doi: 10.1080/08880018.2021.1955059. Epub 2021 Aug 9.
2
St. Jude Cloud: A Pediatric Cancer Genomic Data-Sharing Ecosystem.圣裘德云:儿科癌症基因组数据共享生态系统。
Cancer Discov. 2021 May;11(5):1082-1099. doi: 10.1158/2159-8290.CD-20-1230. Epub 2021 Jan 6.
3
Attempts to optimize postinduction treatment in childhood acute myeloid leukemia without core-binding factors: A report from the Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG).
在 CAR-T 细胞和blinatumomab 治疗后,KMT2A 野生型谱系转换白血病的克隆起源。
Nat Cancer. 2023 Aug;4(8):1095-1101. doi: 10.1038/s43018-023-00604-0. Epub 2023 Jul 20.
尝试优化无核心结合因子的儿童急性髓细胞白血病的诱导后治疗:来自日本儿科白血病/淋巴瘤研究组(JPLSG)的报告。
Pediatr Blood Cancer. 2020 Dec;67(12):e28692. doi: 10.1002/pbc.28692. Epub 2020 Sep 4.
4
A risk-stratified therapy for infants with acute lymphoblastic leukemia: a report from the JPLSG MLL-10 trial.分层风险治疗急性淋巴细胞白血病患儿:来自 JPLSG MLL-10 试验的报告。
Blood. 2020 Oct 15;136(16):1813-1823. doi: 10.1182/blood.2019004741.
5
PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia.PAX5 驱动的 B 系前体细胞急性淋巴细胞白血病亚型。
Nat Genet. 2019 Feb;51(2):296-307. doi: 10.1038/s41588-018-0315-5. Epub 2019 Jan 14.
6
The MLL recombinome of acute leukemias in 2017.2017 年急性白血病的 MLL 重排组。
Leukemia. 2018 Feb;32(2):273-284. doi: 10.1038/leu.2017.213. Epub 2017 Jul 13.
7
Integrated genetic and epigenetic analysis defines novel molecular subgroups in rhabdomyosarcoma.综合遗传和表观遗传分析定义横纹肌肉瘤的新型分子亚群。
Nat Commun. 2015 Jul 3;6:7557. doi: 10.1038/ncomms8557.
8
Rise and fall of subclones from diagnosis to relapse in pediatric B-acute lymphoblastic leukaemia.儿童B系急性淋巴细胞白血病从诊断到复发过程中克隆亚群的兴衰
Nat Commun. 2015 Mar 19;6:6604. doi: 10.1038/ncomms7604.
9
The landscape of somatic mutations in infant MLL-rearranged acute lymphoblastic leukemias.婴儿MLL重排急性淋巴细胞白血病的体细胞突变图谱。
Nat Genet. 2015 Apr;47(4):330-7. doi: 10.1038/ng.3230. Epub 2015 Mar 2.
10
Cell of origin determines clinically relevant subtypes of MLL-rearranged AML.原始细胞决定了具有临床意义的 MLL 重排 AML 亚型。
Leukemia. 2013 Apr;27(4):852-60. doi: 10.1038/leu.2012.363. Epub 2012 Dec 13.